Bagger-Sørensen Equity completes first investment within Healthcare

Bagger-Sørensen Equity completes minority investment in the Danish MedTech company Cercare Medical, a leading expert in complex algorithms enabling advanced Perfusion Imaging in MR and CT scans.

Cercare Medical is a medical software company founded in 2013 as a spin-out of the Center of Functionally Integrative Neuroscience at Aarhus University, Denmark. They develop advanced perfusion software providing medical healthcare professionals significantly more detailed MR and CT images. Further, by leveraging Artificial intelligence, Cercare Medical’s perfusion software enhances the accuracy, efficiency, and speed of image analysis, providing medical healthcare professionals invaluable insights and diagnostics support to make better decisions in the fields of i.e., Brain Oncology and Ischemic Stroke Assessments. Ved at udnytte kunstig intelligens øger Cercare Medicals perfusionssoftware nøjagtigheden og effektiviteten af billedanalyse og giver sundhedspersonale uvurderlig indsigt og diagnostisk støtte til at træffe bedre beslutninger inden for hjerneonkologi og iskæmisk slagtilfælde.

We are proud to invest in a company contributing to improved patient outcomes, enhanced decision-making for medical healthcare professionals, and, ultimately, a positive impact on the lives of individuals facing potentially challenging medical conditions. Bagger-Sørensen Equity focuses its investments within Healthcare, Food & Ingredients, Technology and Sustainability. The investment in Cercare Medical represents an important milestone for Bagger-Sørensen Equity as the first investment within Healthcare. With the Cercare Medical investment, Bagger-Sørensen Equity can celebrate its eight investment, since being established in 2020.

Further information

Søren Birn, CEO Bagger-Sørensen Equity
E-mail: bir@baggersorensen.com